Search Index Entries

2178 Results
TitlePublication
Remdesivir for COVID-19: real-time meta analysis of 79 studies
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialThe Lancet Infectious Diseases
Renal Complications Following COVID-19 Vaccination: A Narrative Literature ReviewIndian Journal of Community Medicine
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adultsImmunity & Ageing
Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort StudyCancers
Reply to Fung et al. on COVID‐19 vaccine case‐countingwindow biases overstating vaccine effectivenessJournal of Evaluation in Clinical Practice
Report 12: The Global Impact of COVID-19 and Strategies for Mitigation and Suppression
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
Report an Adverse Event to VAERS
Report to the Committees on Armed Services of the Senate and the House of Representatives - Study and Report on Health Conditions of Members of the Armed Forces Developed after Administration of COVID–19 VaccineReport to the Committees on Armed Services of the Senate and the House of Representatives
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewPLOS Medicine
Reports of acute adverse events in mRNA COVID‑19 vaccine recipients after the first and second doses in JapanScientific Reports
Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of DeathScience, Public Health Policy and the Law
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and SwedenMedicina
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesJAMA Network Open
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic PossibilitiesFrontiers in Immunology
Research Letter re. 'Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis'Journal of the American Academy of Dermatology
Research Letter: Acute Allergic Reactions to mRNA COVID-19 VaccinesJAMA (Journal of the American Medical Association)
Research Letter: All-Cause Excess Mortality and COVID-19 - Related Mortality Among US Adults Aged 25-44 Years, March-July 2020JAMA (Journal of the American Medical Association)
Research Letter: Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, ItalyJAMA Internal Medicine
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast MilkJAMA Pediatrics
Research Letter: Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron VariantJAMA Network Open
Researchers studying reported menstrual changes after COVID-19 vaccination
Reset the Table: Meeting the Moment to Transform the U.S. Food System
Resignation in protest, Frontiers in Pharmacology - Topic Editors, “Treating COVID-19 With Currently Available Drugs”
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically
Response to Critics of Lee & Broudy (2024) on the Toxicity and Self-Assembling Technology in Incubated Samples of InjectaInternational Journal of Vaccine Theory, Practice, and Research
Response to Request for Information (RFI): COVID-19 Misinformation from Official Sources During the Pandemic
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statistics
Results of a systematic review and meta‑analysis of early studies on ivermectin in SARS‑CoV‑2 infectionGeroScience
Results of an Open Prospective Controlled Comparative Study on the Treatment of Novel Coronavirus Infection (COVID-19): Bromhexine & Spironolactone for the Treatment of Coronavirus Infection Requiring HospitalizationKardiologiia
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In VitroViruses
Retracted Covid-19 articles: significantly more cited than other articles within their journal of originScientometrics
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2Medical Science Monitor
Return to Wuhan: What Life Is Like One Year LaterNBC News
Revealed: PR firm that represents Pfizer and Moderna also sits on CDC vaccine division - sparking major conflict of interest concernsDaily Mail
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissuesProceedings of the National Academy of Sciences
Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic reviewAnnals of Medicine & Surgery
Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological DegenerationJournal of Medical-Clinical Research & Reviews
Review of scientific reports of harms caused by face masks, up to February 2021
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19American Journal of Therapeutics
Review: Calls for Market Removal of COVID-19 Vaccines Intensify: Risks Far Outweigh Theoretical BenefitsScience, Public Health Policy and the Law
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?International Journal of Biological Macromolecules
Revisiting Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements—United States, July 1—October 20 2021Preprints with The Lancet
Rhabdomyolysis Secondary to COVID-19 VaccinationCureus
Ribosomal frameshifting and misreading of mRNA in COVID-19 vaccines produces “off-target” proteins and immune responses eliciting safety concerns: Comment on UK study by Mulroney et al.
Risk assessment of retinal vascular occlusion after COVID-19 vaccinationnpj Vaccines
Risk assessment of retinal vascular occlusion after COVID-19 vaccinationnpj Vaccines
Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022Emerging Infectious Diseases